• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者对健康状态偏好的多属性模型。

A multi-attribute model of prostate cancer patient's preferences for health states.

作者信息

Chapman G B, Elstein A S, Kuzel T M, Nadler R B, Sharifi R, Bennett C L

机构信息

Rutgers University, Department of Psychology, Piscataway, NJ 08854-8020, USA.

出版信息

Qual Life Res. 1999 May;8(3):171-80. doi: 10.1023/a:1008850610569.

DOI:10.1023/a:1008850610569
PMID:10472149
Abstract

Multi-attribute utility theory (MAUT) provides a way to model decisions involving trade-offs among different aspects or goals of a problem. We used MAUT to model prostate cancer patients' preferences for their own health state and we compared this model to patients' global judgments of health state utility. 57 patients with prostate cancer (mean age = 70) at two Chicago Veterans Administration health clinics were asked to evaluate health states described in terms of five health attributes affected by prostate cancer: pain, mood, sexual function, bladder and bowel function, and fatigue and energy. Each attribute had three levels that were used to form three clinically realistic health state descriptions (A = high, B = moderate, C = low). A fourth personalized health description (P) matched the patient's current health. We first measured patients' preferences using time trade-off (TTO) judgments for the three health states (A, B, and C) and for their own current health state (P). The TTO for the patient's own health state (P) was standardized by comparing it to TTO judgments for states A and C. We next constructed a multi-attribute model using the relative importance of the five attributes. The MAU scores were moderately correlated with the TTO preference judgments for the personalized state (Pearson r = 0.38, N = 57, p < 0.01). Thus, patients' preference judgments are moderately consistent and systematic. MAUT appears to be a potentially feasible method for evaluating preferences of prostate cancer patients and may prove helpful in assisting with patient decision making.

摘要

多属性效用理论(MAUT)提供了一种对涉及问题不同方面或目标之间权衡的决策进行建模的方法。我们使用MAUT对前列腺癌患者对自身健康状态的偏好进行建模,并将该模型与患者对健康状态效用的总体判断进行比较。在芝加哥的两家退伍军人管理局医疗诊所,57名前列腺癌患者(平均年龄 = 70岁)被要求对由前列腺癌影响的五个健康属性所描述的健康状态进行评估:疼痛、情绪、性功能、膀胱和肠道功能以及疲劳和精力。每个属性有三个级别,用于形成三种符合临床实际的健康状态描述(A = 高,B = 中,C = 低)。第四个个性化健康描述(P)与患者当前的健康状况相匹配。我们首先使用时间权衡(TTO)判断来测量患者对三种健康状态(A、B和C)以及他们自己当前健康状态(P)的偏好。通过将患者自身健康状态(P)的TTO与状态A和C的TTO判断进行比较,对其进行标准化。接下来,我们使用五个属性的相对重要性构建了一个多属性模型。MAU得分与个性化状态的TTO偏好判断呈中度相关(Pearson相关系数r = 0.38,N = 57,p < 0.01)。因此,患者的偏好判断具有一定程度的一致性和系统性。MAUT似乎是一种评估前列腺癌患者偏好的潜在可行方法,可能有助于辅助患者进行决策。

相似文献

1
A multi-attribute model of prostate cancer patient's preferences for health states.前列腺癌患者对健康状态偏好的多属性模型。
Qual Life Res. 1999 May;8(3):171-80. doi: 10.1023/a:1008850610569.
2
Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.双相I型障碍患者当前健康状况的健康状态效用值
J Ment Health Policy Econ. 2018 Mar 1;21(1):3-10.
3
Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives.从三种不同视角对前列腺癌特定疾病健康状态的效用评估。
Appl Health Econ Health Policy. 2017 Jun;15(3):375-384. doi: 10.1007/s40258-016-0282-x.
4
Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer.接受三维适形放疗的前列腺癌男性患者偏好和效用的预测因素。
Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):34-42. doi: 10.1016/s0360-3016(03)01434-2.
5
Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?局限性前列腺癌治疗的副作用:患者和健康对照对其的重视程度是否不同?
BJU Int. 2007 Apr;99(4):801-6. doi: 10.1111/j.1464-410X.2006.06707.x. Epub 2007 Jan 16.
6
Patients' values and clinical substituted judgments: the case of localized prostate cancer.患者价值观与临床替代判断:局限性前列腺癌病例
Health Psychol. 2005 Jul;24(4S):S85-92. doi: 10.1037/0278-6133.24.4.S85.
7
Evaluation of an internet-based disease trajectory decision tool for prostate cancer screening.基于互联网的前列腺癌筛查疾病轨迹决策工具的评估
Value Health. 2009 Jan-Feb;12(1):101-8. doi: 10.1111/j.1524-4733.2008.00407.x. Epub 2008 Jul 11.
8
Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.前列腺癌患者及社区对治疗结果的偏好:对临床政策的影响
Med Care. 2003 Jan;41(1):153-64. doi: 10.1097/00005650-200301000-00017.
9
Estimating preferences for treatments in patients with localized prostate cancer.估算局限性前列腺癌患者对治疗的偏好。
Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):277-87. doi: 10.1016/j.ijrobp.2014.09.044. Epub 2014 Dec 6.
10
Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.前列腺癌患者与其临床医生之间关于效用和属性重要性的共识。
Health Expect. 2004 Jun;7(2):115-25. doi: 10.1111/j.1369-7625.2004.00267.x.

引用本文的文献

1
A Randomized Controlled Trial of Strategies to Improve Family Members' Preparedness for Surrogate Decision-Making.一项关于提高家庭成员代理决策准备度策略的随机对照试验。
Am J Hosp Palliat Care. 2018 Jun;35(6):866-874. doi: 10.1177/1049909117744554. Epub 2017 Nov 29.
2
Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer.需要生存获益来抵消局限性前列腺癌持续的不利治疗效果。
Br J Cancer. 2012 Feb 14;106(4):638-45. doi: 10.1038/bjc.2011.552. Epub 2012 Jan 24.
3
A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life.

本文引用的文献

1
Prostate cancer patients' utilities for health states: how it looks depends on where you stand.前列腺癌患者对健康状态的效用:情况如何取决于你的立场。
Med Decis Making. 1998 Jul-Sep;18(3):278-86. doi: 10.1177/0272989X9801800304.
2
A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians.
Eur Urol. 1997;32 Suppl 3:86-8.
3
Multiattribute utility assessment of outcomes of treatment for head and neck cancer.头颈癌治疗结果的多属性效用评估
一项随机研究,比较表柔比星每4周静脉注射方案与每周静脉注射方案用于转移性、激素抵抗性前列腺癌患者的疗效:对健康相关生活质量的影响。
World J Urol. 2003 Aug;21(3):177-82. doi: 10.1007/s00345-003-0342-3. Epub 2003 Jun 18.
4
"I can't afford that!": dilemmas in the care of the uninsured and underinsured.“我负担不起!”: uninsured和underinsured人群护理中的困境
J Gen Intern Med. 2001 Jun;16(6):412-8. doi: 10.1046/j.1525-1497.2001.016006412.x.
5
Evaluating the relationship between pain presentation and health-related quality of life in outpatients with metastatic or recurrent neoplastic disease.
Qual Life Res. 2000;9(7):855-63. doi: 10.1023/a:1008944211294.
Br J Cancer. 1997;75(6):898-902. doi: 10.1038/bjc.1997.158.
4
Measurement of patient-derived utility values for periodontal health using a multi-attribute scale.使用多属性量表测量患者来源的牙周健康效用值。
J Clin Periodontol. 1996 Sep;23(9):805-9. doi: 10.1111/j.1600-051x.1996.tb00615.x.
5
Tradeoffs between quality and quantity of life: development of the QQ Questionnaire for Cancer Patient Attitudes.生活质量与数量之间的权衡:癌症患者态度QQ问卷的编制
Med Decis Making. 1996 Apr-Jun;16(2):184-92. doi: 10.1177/0272989X9601600211.
6
Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2.用于综合健康状况分类系统的多属性效用函数。健康效用指数Mark 2。
Med Care. 1996 Jul;34(7):702-22. doi: 10.1097/00005650-199607000-00004.
7
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?氟他胺用于前列腺癌患者的成本效益模型:它们对政策制定者有帮助吗?
Cancer. 1996 May 1;77(9):1854-61. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1854::AID-CNCR15>3.0.CO;2-Z.
8
ComputerLink: the impact of a computer network on Alzheimer's caregivers' decision-making confidence and skill.计算机链接:计算机网络对阿尔茨海默病护理者决策信心和技能的影响。
Medinfo. 1995;8 Pt 2:1546.
9
A multiattribute-utility-function approach to weighing the risks and benefits of pharmaceutical agents.一种用于权衡药物风险与益处的多属性效用函数方法。
Med Decis Making. 1993 Apr-Jun;13(2):118-25. doi: 10.1177/0272989X9301300205.
10
A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy.接受或未接受激素治疗的转移性前列腺癌患者的生活质量比较。
Cancer. 1993 Feb 1;71(3 Suppl):1143-50. doi: 10.1002/1097-0142(19930201)71:3+<1143::aid-cncr2820711437>3.0.co;2-i.